Selling to formulators, not to patients.
Active pharmaceutical ingredient manufacturers sell to formulators and drug product companies, a B2B audience evaluating manufacturing capability, regulatory documentation and supply reliability, never a patient-facing conversation.
A formulator evaluating an API supplier checks regulatory filings, manufacturing capability and supply chain reliability closely, often as part of a formal qualification process. The site needs to support that technical due diligence, not market a product.
Content structured around manufacturing capability and regulatory documentation, a product range presented by chemical and regulatory category, and technical documentation made findable for a formulator’s qualification process.
What we present about your regulatory filings is confirmed by your quality and regulatory team; our job is structuring it so a technical buyer can evaluate it efficiently.
The scope our work with API manufacturers has operated within.
The build priorities for a technical qualification process differ from a consumer or clinical audience. Here is what API manufacturers most often need.
How this work is approached specifically for API Manufacturers.
What comes up when building for an active ingredient manufacturer.
DMF and CEP status by market is exactly the kind of detail a formulator checks early in technical due diligence, so it is structured as findable, filterable data rather than a note buried inside a PDF specification sheet. Making that status transparent up front shortens the qualification stage that would otherwise happen through repeated email exchanges with your regulatory affairs team before a formulator even requests a sample.
Custom synthesis and catalogue API offerings generally need separate presentation, since a formulator evaluating custom synthesis is judging your process chemistry and scale-up capability while a buyer sourcing an established catalogue API is comparing specification, DMF status and lead time instead. Structuring the site around that difference lets both audiences find what they need directly, rather than forcing a commercial buyer to read through capability narrative meant for a development partner.
The structure is built around the specific way a formulator conducts technical due diligence, including regulatory filing findability, impurity profiles and route-of-synthesis detail, rather than the generic capability-and-contact-form template a general industrial B2B site typically uses. A formulator qualifying a new API supplier works through a defined technical checklist before ever making contact, so the site needs to answer that checklist directly rather than waiting for an inquiry.
A formal qualification process moves faster when the documentation it requires is readily findable and well organised on the site, which is often the bottleneck rather than the underlying technical or regulatory substance. Formulators frequently stall qualification waiting on documents that exist but are hard to locate, so structuring specifications, DMF references and quality certifications as searchable content removes a delay that is unrelated to the API itself.
Related sectors worth reviewing alongside API manufacturers.
Capability and documentation that need to reach formulators conducting qualification. Tell us your specialisation and we will tell you how we would approach it for an API manufacturer.